Nodality (San Francisco, CA) a development-stage molecular diagnostics company focused on hematological malignancies and autoimmune disorders, closed a $3.5M Series C financing. Participants have included Kleiner Perkins Caufield & Byers, Maverick Capital, Pfizer and TPG Ventures.

Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.